SCHEDULE 13G: BlackRock Discloses 5.01% Stake in Sight Sciences
Beneficial Ownership Report
BlackRock, Inc. has reported a beneficial ownership of 5.01% of Sight Sciences, Inc.'s common stock as of December 31, 2025.
Summary
- BlackRock, Inc. filed a Schedule 13G, indicating beneficial ownership of 2,651,156 shares of Sight Sciences, Inc. common stock.
- This ownership represents 5.01% of the total outstanding common stock of Sight Sciences, Inc.
- BlackRock holds sole voting power over 2,614,209 shares and sole dispositive power over 2,651,156 shares.
- The filing was made by various business units of BlackRock, Inc. and its subsidiaries and affiliates, including BlackRock Advisors, LLC, BlackRock Asset Management Canada Limited, BlackRock Fund Advisors, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., and BlackRock Investment Management, LLC.
Sentiment
Score: 5
Explanation: A Schedule 13G is a routine disclosure of beneficial ownership by an institutional investor, inherently neutral in sentiment regarding the issuer's performance, but the presence of a major investor like BlackRock can be seen as a neutral to slightly positive signal.
Positives
- A significant institutional investor, BlackRock, Inc., has disclosed a 5.01% stake in Sight Sciences, Inc., indicating a notable investment position.
Future Outlook
NA
Management Comments
- The securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
Industry Context
This filing is a routine disclosure of institutional ownership and does not provide specific industry context or analysis of Sight Sciences, Inc.'s market position relative to broader industry trends.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership in Sight Sciences, Inc.
- Investors: Offers insight into the investment positions of major financial institutions in the company.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney dated April 30, 2023, was revoked. |
| 2025-01-21 | New Power of Attorney executed by BlackRock, Inc. |
| 2025-12-31 | Date of the event which required the filing of this statement. |
| 2026-01-21 | Date of filing of this Schedule 13G. |
Keywords
BlackRock, Sight Sciences, Institutional Ownership, Schedule 13G, Common Stock, Beneficial Ownership, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.